SOC

Surgery on Children Journal aims to publish issues related to Pediatric Surgery, Pediatric Neurosurgery, Pediatric Plastic Surgery, Pediatric Cardiovascular Surgery, Pediatric Orthopedic Surgery, Pediatric Vascular Surgery, Pediatric Gynecology and Obstetrics, Pediatric Ear Nose Throat, Ophthalmology, Pediatric Anesthesiology and Reanimation, Pediatric Urology, Pediatric Surgical Intensive Care Clinic, and other clinical surgery fields on children of the highest scientific and clinical value at an international level and accepts articles on these topics.

EndNote Style
Index
Original Article
Comparison of short-chain fatty acid (SCFA) patterns in children with and without hirschsprung’s disease
Aims: Hirschsprung’s disease (HD) is a congenital gastrointestinal anomaly that causes morbidity and increases the risk of mortality. The increased risk of infection in HD is related to several factors, including dysbiosis of the intestinal microbiota, which plays an important role in maintaining intestinal function through the production of short-chain fatty acids (SCFAs). This study aimed to determine the differences in SCFA levels in children with HD and children without HD.
Methods: This study used an observational analytic cross-sectional design. The subjects were pediatric patients treated at Cipto Mangunkusomo Hospital from January to June 2024 who met the inclusion and exclusion criteria. A total of 17 pediatric patients were included, consisting of 9 children with HD and 8 children without HD. Fecal SCFA levels were analyzed and compared between the two groups.
Results: SCFA levels in children with HD (2.4 ± 1.6) were significantly lower than in children without HD (7.9 ± 2.4) (p < 0.05). There were no statistically significant differences (p > 0.05) between the HD group (n = 9) and the non-HD group (n = 8) in individual SCFA components, including butyrate, propionate, valerate, and acetate levels.
Conclusion: Children with Hirschsprung’s disease have significantly lower total fecal SCFA levels compared to children without Hirschsprung’s disease, while no significant differences were found in individual SCFA components.


1. Kessmann J. Hirschsprung’s disease: diagnosis and management. Am Fam Physician. 2006;74(8):1319-1322.
2. Bradnock TJ, Knight M, Kenny S, Nair M, Walker GM. Hirschsprung’s disease in the UK and Ireland: incidence and anomalies. Arch Dis Child. 2017;102(8):722-727. doi:10.1136/archdischild-2016-311872
3. Demehri FR, Halaweish IF, Coran AG, Teitelbaum DH. Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention. Pediatr Surg Int. 2013;29(9):873-881. doi:10.1007/s00383-013-3353-1
4. Frykman PK, Short SS. Hirschsprung-associated enterocolitis: prevention and therapy. Semin Pediatr Surg. 2012;21(4):328-335. doi:10. 1053/j.sempedsurg.2012.07.007
5. Sakurai T, Tanaka H, Endo N. Predictive factors for the development of postoperative Hirschsprung-associated enterocolitis in children operated during infancy. Pediatr Surg Int. 2021;37(2):275-280. doi:10. 1007/s00383-020-04784-z
6. Chantakhow S, Khorana J, Tepmalai K, Boonchooduang N, Chattipakorn N, Chattipakorn SC. Alterations of gut bacteria in Hirschsprung disease and Hirschsprung-associated enterocolitis. Microorganisms. 2021;9(11):2241. doi:10.3390/microorganisms9112241
7. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189-200. doi:10.1080/19490976.2015.1134082
8. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221-1227. doi:10.1136/gut.28.10.1221
9. Ohira H, Tsutsui W, Fujioka Y. Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis? J Atheroscler Thromb. 2017;24(7):660-672. doi:10.5551/jat.RV17006
10. Rao SC, Esvaran M, Patole SK, et al. Gut microbiota in neonates with congenital gastrointestinal surgical conditions: a prospective study. Pediatr Res. 2020;88(6):878-886. doi:10.1038/s41390-020-0824-7
11. Chi C, Xue Y, Lv N, et al. Longitudinal gut bacterial colonization and its influencing factors of low birth weight infants during the first 3 months of life. Front Microbiol. 2019;10:1105. doi:10.3389/fmicb.2019.01105
12. Granéli C, Dahlin E, Börjesson A, Arnbjörnsson E, Stenström P. Diagnosis, symptoms, and outcomes of Hirschsprung’s disease from the perspective of gender. Surg Res Pract. 2017;2017:9274940. doi:10. 1155/2017/9274940
13. Liu W, Yan H, Jia W, et al. Association between gut microbiota and Hirschsprung disease: a bidirectional two-sample Mendelian randomization study. Front Microbiol. 2024;15:1366181. doi:10.3389/fmicb.2024.1366181
14. Li S, Zhang Y, Li K, et al. Update on the pathogenesis of the Hirschsprung-associated enterocolitis. Int J Mol Sci. 2023;24(5):4602. doi:10.3390/ijms24054602
15. Tang W, Su Y, Yuan C, et al. Prospective study reveals a microbiome signature that predicts the occurrence of post-operative enterocolitis in Hirschsprung disease patients. Gut Microbes. 2020;11(4):842-854. doi:10. 1080/19490976.2020.1711685
16. Plekhova V, De Paepe E, Van Renterghem K, Van Winckel M, Hemeryck LY, Vanhaecke L. Disparities in the gut metabolome of post-operative Hirschsprung’s disease patients. Sci Rep. 2021;11(1):16167. doi:10.1038/s41598-021-95589-0
17. Prato A, Bartow-McKenney C, Hudspeth K, et al. A metagenomics study on Hirschsprung’s disease associated enterocolitis: biodiversity and gut microbial homeostasis depend on resection length and patient’s clinical history. Front Pediatr. 2019;7:326. doi:10.3389/fped.2019.00326
Volume 3, Issue 2, 2026
Page : 43-46
_Footer